Indeed, our results revealed that doxorubicin treatment can trigger ferroptosis, and SH3GL1 overexpression mitigated the effects of doxorubicin‐induced ferroptosis in DLBCL cell lines, thereby reducing the sensitivity of DLBCL cells to doxorubicin. This evidence concerns the gene SH3GL1 and diffuse large B-cell lymphoma.